Skip to main content
OpenTrials

Clinical trial condition

Hyperparathyroidism, Secondary

Explore clinical trials studying Hyperparathyroidism, Secondary. Study availability and eligibility vary by location and protocol.

146 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Hyperparathyroidism, Secondary trial results

Completed

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

NCT00977080

Conditions
Chronic Disease, Chronic Kidney Disease, Disease Attributes, +16 more
Locations
  • Site Reference ID/Investigator# 22781 Tempe, Arizona, United States
  • Site Reference ID/Investigator# 24342 Chula Vista, California, United States
  • Site Reference ID/Investigator# 21142 Los Angeles, California, United States
  • Site Reference ID/Investigator# 22762 Los Angeles, California, United States
View all 83 locations
View Trial Details
Completed

Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level

NCT01101113

Conditions
Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations
  • Seoul National University Hospital Seoul, Korea, South Korea
  • Kyungpook National University Daegu, South Korea
  • Gil Hospital Incheon, South Korea
  • Hallym University Sacred Hospital Pyungchon, South Korea
View Trial Details
Completed

Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent and Treat Secondary Hyperparathyroidism

NCT01081665

Conditions
Chronic Disease, Chronic Kidney Failure, Disease Attributes, +16 more
Locations
  • Site Reference ID/Investigator# 32055 Athens, Greece
  • Site Reference ID/Investigator# 32050 Athens, Greece
  • Site Reference ID/Investigator# 32051 Athens, Greece
  • Site Reference ID/Investigator# 32049 Athens, Greece
View all 19 locations
View Trial Details
Completed

Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyroid Hormone in Chronic Kidney Disease

NCT01071070

Conditions
Chronic Disease, Chronic Kidney Disease, Disease Attributes, +14 more
Locations
  • Site Reference ID/Investigator# 23483 Beijing, China
  • Site Reference ID/Investigator# 23485 Beijing, China
  • Site Reference ID/Investigator# 23482 Beijing, China
  • Site Reference ID/Investigator# 23484 Dalian, China
View Trial Details
Completed

Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis

NCT00537979

Conditions
Dialysis, Endocrine System Diseases, Hyperparathyroidism, +3 more
Locations
  • Site Ref # / Investigator 19391 Jojutla Morelos, Mexico
  • Site Ref # / Investigator 19392 Mexico City, Mexico
  • Site Ref # / Investigator 19397 Mexico City, Mexico
  • Site Ref # / Investigator 19396 Mexico City, Mexico
View Trial Details
Completed

Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoing Haemodialysis

NCT01084538

Conditions
Endocrine System Diseases, Hyperparathyroidism, Hyperparathyroidism, Secondary, +2 more
Locations
  • Site Reference ID/Investigator# 27525 Dubrovnik, Croatia
  • Site Reference ID/Investigator# 27531 Imotski, Croatia
  • Site Reference ID/Investigator# 6175 Karlovac, Croatia
  • Site Reference ID/Investigator# 27528 Pula, Croatia
View all 21 locations
View Trial Details
Completed

Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism

NCT00990704

Conditions
Endocrine System Diseases, Hemodialysis, Hyperparathyroidism, +3 more
Locations
  • Site Ref # / Investigator 53794 Anjo, Japan
  • Site Ref # / Investigator 53787 Chiba, Japan
  • Site Ref # / Investigator 53786 Kumagaya, Japan
  • Site Ref # / Investigator 53792 Matsumoto, Japan
View all 14 locations
View Trial Details

Related conditions